Development of Radiation/Nuclear Medical Countermeasures (MCMs) And Biodosimetry Devices
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is presoliciting for a Broad Agency Announcement (BAA) titled "Development of Radiation/Nuclear Medical Countermeasures (MCMs) And Biodosimetry Devices." This initiative aims to advance products for assessing, diagnosing, mitigating, and treating radiation injuries from radiological or nuclear incidents. The BAA is expected to be available on February 4, 2026.
Scope of Work
NIAID intends to solicit proposals to advance candidate biodosimetry signatures/devices or MCMs. The goal is to assess injuries and/or reduce mortality and major morbidities associated with radiation exposure during a public health emergency. Research and development studies will advance lead candidates toward eventual FDA clearance, approval, or licensure. Offerors will provide a Statement of Work (SOW) based on the candidate's stage, which can range from mid-stage research to post-marketing.
Contract & Timeline
- Type: Presolicitation for Broad Agency Announcement (BAA) contracts
- Duration: Up to 3 years
- Estimated Value: Average $2 million annually, up to $6 million total over three years
- Set-Aside: None specified (Any responsible offeror may submit)
- BAA Availability: February 4, 2026
- Published: January 15, 2026
Evaluation
Proposals will be evaluated on:
- Availability of data supporting detection of exposure, prediction of injuries, or amelioration by candidate MCMs.
- Adequacy of the proposed scientific approach and methodology.
- Adequacy of scientific/technical personnel, facilities, equipment, GLP, cGMP compliance (if applicable), and project management.
Additional Notes
Proposals must be submitted via the NIAID electronic Contract Proposal Submission (eCPS) website (https://ecps.nih.gov/). Facsimile or email submissions are not acceptable. This notice does not commit the Government to award a contract.